Introduction
ErbB-2, a member of the epidermal growth factor (EGF) receptor tyrosine kinase (RTK) family, is over expressed in 20-30% of primary human breast cancers, reviewed in Hynes and Stern (1994) . Overexpression or activation of this gene prognosticates a poor outcome for patients (Ross and Fletcher, 1999 ). The precise mechanism by which ErbB-2 activation leads to oncogenic transformation or metastasis of epithelial cells is unknown. Ligand binding induces homo-or heterodimerization of the ErbB receptor family members, resulting in the autophosphorylation of distinct tyrosine residues located within the carboxy-tail cytoplasmic domain (Schlessinger, 2000) . The primary function of RTK tyrosine phosphorylation is to generate binding sites for cytoplasmic or plasma membrane-associated proteins involved in transducing proliferative or differentiating signals to the nucleus. These signalling proteins each contain modular Src homology 2 (SH2) or protein tyrosine binding (PTB) domains enabling direct interaction in a phosphotyrosine-dependent and sequence-specific manner (Pawson, 1994; van der Geer and Pawson, 1995) . Therefore, each phosphorylated tyrosine residue (pTyr) recruits different adaptor proteins to the receptor Songyang et al., 1993; Margolis et al., 1999) . These proteins may be enzymes, including kinases, phosphatases or phospholipases, which further activate intracellular signalling cascades. Other adaptors act as intermediates, to link other enzymes to the signalling complex, or activate them by association with the membrane. For instance, Grb-2 associates with RTKs through its SH2 domain, and will recruit the guanine nucleotide exchange factor Sos through its SH3 domain, leading to the activation of downstream Ras effectors such as Raf and PI3'K RozakisAdcock et al., 1993; Simon and Schreiber, 1995) .
Most RTKs can recruit multiple second messengers, each providing discrete outputs into an intracellular signalling network. This network is often robust enough to function effectively in the absence of one pTyractivated pathway (Dankort et al., 1997; Lesa and Sternberg, 1997; Gayko et al., 1999) . Four of five individual pTyrs of activated Neu, the rat ErbB-2 homolog, appear to contribute individually to cell transformation of cultured fibroblasts (Dankort et al., 1997) , although a single pTyr cannot substitute for signalling from a wild-type RTK. In the case of Neu, single pTyrs that couple to the Ras pathway through Shc (Y1227) or Grb-2 (Y1144) can act to transform cultured fibroblasts (Dankort et al., 1997 (Dankort et al., , 2001 ). However, in the context of a living organism, signalling through Grb-2 alone in mammary epithelia in vivo results in a higher rate of metastasis than signalling through Shc alone (Dankort et al., 2001 ).
The identification of pTyr outputs is largely built upon data from peptide inhibition, labelling of phosphotyrosines, and protein coimmunoprecipitation experiments in vitro (reviewed by Pawson and Nash (2000) and Schlessinger (2000) ). The correlative nature of these assays precludes the functional identification of bona fide adaptors, and must be validated by functional assessment in vivo. In vivo assays reveal more functional distinctions of different pTyr outputs (Lesa and Sternberg, 1997; Dankort et al., 2001) .
Genetic analysis can provide an efficient means of identifying signal pathways in vivo. The function of many SH2/PTB proteins in signalling is conserved in genetic model organisms like Caenorhabditis elegans and Drosophila. Human GRB2 and Drosophila Drk can rescue sem-5 function in C. elegans, for example, and SEM5 associates with the human EGF receptor as well (Stern et al., 1993) . Given the structural conservation of RTK signalling pathways among metazoans, we asked whether the adaptor binding ('docking') sites of a vertebrate RTK could successfully signal through adaptor proteins in Drosophila, an organism more amenable to genetic dissection of signal transduction. Many genes required for signal transduction exhibit gene-dosage-dependent phenotypes (Rogge et al., 1991; Simon et al., 1991; Lu et al., 1994; Firth et al., 2000) . Therefore, genetic screens to detect dosage-sensitive modifiers of phenotypes created by misexpression of an activated RTK-like Neu should reveal which gene functions are required to transduce Neu signals. This approach may also indicate which adaptors are required downstream of identified pTyr of Neu.
Simultaneous point mutation of the five known pTyrs of Neu, creating a Neu tyrosine phosphorylation deficient (Neu NYPD ) allele, demonstrated that most of the oncogenic but not catalytic activity occurs through the pTyr. Reconstitution of single pTyr to Neu NYPD (an 'add-back mutant', here termed 'add-back allele') demonstrates that transformation can be independently mediated through four of five Neu pTyr sites (Dankort et al., 1997; Dankort and Muller, 2000) . In this study, we express these characterized neu alleles in Drosophila tissues known to require DEgfr signalling during pattern formation. Misexpression of neu alleles generates phenotypes similar to increased activation of DEgfr, and dosage-dependent lethal effects. We establish here that these phenotypes are suitable for analysis by dosage-sensitive modifier genetics, and allow us to identify which Drosophila adaptors and second messengers function downstream of specific pTyr of Neu. The neu add-back alleles provide a tool to activate only a subset of downstream effectors, and thereby allow identification of genes that might normally be missed because of functional redundancy. This model provides a starting point for a genetic approach to study the requirements in analogous pathways for the genesis and progression of human neoplasia.
Results

Conserved structure of the docking domain
If the mechanism of adaptor recognition was strongly conserved, we would anticipate that the docking region of related RTKs would show strong sequence similarity. Sequence comparison of Neu with DEgfr revealed that the docking domain is the least conserved (31% aminoacid similarity) relative to the rest of the receptor (56% for the ligand binding domain and 79% for the kinase domain). Different RTKs can have strikingly different numbers of pTyr sites, so we elected to compare the amino-acid sequence neighbouring the known pTyr of Neu with the better characterized invertebrate RTKs (Table 1) . Similar sequences were identified for all Neu pTyr, but no single invertebrate RTK has similar sequences comparable to each of the known Neu adaptor binding sites. In addition, Neu apparently lacks sequences similar to known Drosophila RTK outputs, for instance Csw (SHP2) (Cunnick et al., 2001) . (Songyang et al., 1993) NPXY peptides block SHC in Drosophila (Lai et al., 1995) low affinity SHC binding in Neu (Kavanaugh et al., 1995) YYN motif, Grb-2 binding (van der Geer et al., 1996) or SHC in Neu (Dankort et al., 1997) or SHC in Neu (Kavanaugh et al., 1995; Ricci et al., 1995) Neu activates Drosophila effector pathways M Settle et al Drosophila DEgfr and Torso RTKs do not have a site similar to YB, known to bind Grb-2 in vitro. The extent of sequence similarity was sometimes different from that predicted from peptide binding assays. For instance, peptide binding studies would predict that hydrophobic residues flank asparagine in the YXNX motif which binds Grb-2 (Songyang et al., 1994) . However, polar glutamic acid flanks asparagine in the most similar invertebrate sequences. In contrast, DEgfr shares an NPEYL sequence with Neu YC and YE. Peptide blocking studies predict that any NPXY peptide is sufficient to inhibit Shc binding to DEgfr (Lai et al., 1995) . Unfortunately, most peptide studies have focused on mammalian rather than Drosophila SH2/PTB proteins. These data reveal some correlations with in vitro peptide binding predictions; however, they were not sufficient to predict which Drosophila adaptors may bind specific Neu pTyr.
To explore the functional conservation of adaptor recognition between mammals and invertebrates, we generated Drosophila stocks transgenic for several 'addback' alleles of neu. Each Neu add-back has all of the known phosphorylated tyrosines in the docking region, save one, converted to phenylalanine (YA, pTyr 1024; YB, pTyr 1144; YC, pTyr 1201; YD, pTyr 1227; YE, pTyr 1253). The neu transgenes also carry an activating mutation that renders Neu constitutively active through increased homodimerization of mutant receptors (Bargmann and Weinberg, 1988; Weiner et al., 1989) . Each of these transgenes, except YA, retains transforming potential in mammalian cells. DEgfr is the Drosophila ortholog to vertebrate ErbB receptors. We targeted expression of neu add-back transgenes in Drosophila tissues known to respond to DEgfr signalling in development, using the GAL4 activation system (Brand et al., 1994) .
Neu signalling suppresses apoptosis in the midline glia (MG) Dosage-dependent signalling by DER has been established in several Drosophila tissues, for instance, positional signalling in the ventral ectoderm or proliferation of malpighian tubule cells (Baumann and Skaer, 1993; Raz and Shilo, 1993) . We elected to characterize signalling in the MG because the output, suppression of apoptosis, is well characterized and the relative levels of signalling are easily quantified by assessing MG cell number (Lanoue and Jacobs, 1999; Jacobs, 2000) . This is scored by expression of the AA142 enhancer trap, which directs expression of nuclear targeted b-galactosidase (Klambt et al., 1991) . From a precursor pool of 10-12 cells per embryonic segment (Dong and Jacobs, 1997), differential apoptosis spares 3 MG ( Figure 1a ). DEgfr signalling, elevated by misexpression of activated DEgfr in the midline of the CNS (DEfgr
A887T
; Lesokhin et al., 1999) , increases MG number to nearly 5 ( Figure 1b Signalling from each 'add-back' allele was tested in the MG apoptosis assay. Neu YA had no significant effect on MG number. In mammalian cells, Neu YA has an inhibitory effect upon RTK signalling (Dankort et al., 1997) . Neu YD , which recruits mammalian Shc proteins (Dankort et al., 1997) , produced the most effective suppression of apoptosis, with potency close to Neu NT ( Figure 1h ). Neu YD is the most transforming in murine fibroblasts as well (Dankort et al., 1997) . Midline expression of the remaining add-back alleles, YB, YC, and YE (Figure 1f , g, and i, respectively), resulted in 4-5 MG per segment.
The GAL4 expression system superimposes neu expression over intrinsic DEgfr function. It is possible that some Neu signals require transactivation of DEgfr, or activation of Neu by DEgfr, if they associate as heterodimers. As kinase-active Neu NYPD had no effect on MG number (Figure 1d) Figure 1l ). Moreover, the activating Neu mutation used functions by inducing homodimers. Thus, we suggest that Neu does not physically interact with DEgfr. DEgfr signalling is a potent activator of Ras, which appears to mediate a significant antiapoptotic signal in the MG (Kurada and White, 1998; Lanoue and Jacobs, 1999) . We sought to determine whether the suppression of apoptosis mediated by Neu similarly required Ras function. Expression of dominant-negative ras N17 in the MG is sufficient to direct all of the MG to apoptosis (Figure 2c ). However, when ras N17 expression was superimposed upon neu NT expression, nearly all MG become apoptotic, indicating that ras function is required to mediate antiapoptotic signals from Neu ( Figure 2d ). Similarly, a haplosufficiency in ras (ras5703/+) attenuated the effect of Neu NT expression on MG number (data not shown). The number of apoptotic profiles in p[sim-GAL4]/+; p[UAS-rasN17]/ p[UAS-neuNT] embryos is greatly increased relative to p[sim-GAL4]/+; p[UAS-rasN17]/+ embryos, indicating that some delay or suppression of apoptosis is signalled independently of Ras (Figure 2c, d ).
Neu Function can be assessed in adult structures
The design of large-scale genetic screens for modifiers of neu-induced phenotypes is simplified when visible adult structures not required for viability are affected. DEgfr Figure 1 Expression of Neu suppresses apoptosis in the midline glia. During normal development, differential apoptosis of 10-12 MG precursors reveals the survival of 3 MG per segment by stage 16 of embryogenesis. The nuclei of the MG were visualized in sagittal view by antibody detection of b-galactosidase, expressed in the MG by the AA142 enhancer trap (a). Activated RTKs were expressed in the midline using sim-GAL4 (see Materials and methods). Expression of an activated form of the Drosophila Egfr in the midline resulted in a 66% increase in MG cell number (b), while similar expression of activated neu more than doubled MG number (c). Expression of neu lacking known pTyr residues had no effect on MG number (d). Midline expression of each of the add-back alleles of neu, YA (e), YB(f), YC(g), YD(h), and YE(i), suppressed apoptosis to differing degrees, elevating MG number between 13 and 100%. Midline expression of a kinase inactive neu transgene with the YD pTyr site intact (neu K757M,YD ) failed to suppress apoptosis in the MG (j). Expression of neu K757M,YD did not affect the suppression of apoptosis resulting from expression of an activated Drosophila EGF receptor (k), but attenuated the antiapoptotic effect of coexpressed neu NT (l). All sagittal views are dorsal at top, anterior to the left. MG counts, s.d., and the number of segments assessed are shown in the lower right of each panel Neu activates Drosophila effector pathways M Settle et al signalling is required for cell proliferation and patterning in both imaginal tissues of the wing and eye. DEgfr signalling in the wing alters wing shape and pattern of wing veins (Sturtevant and Bier, 1995) . DEgfr signalling in the eye changes cell identity, reflected in changes in the patterning of the ommatidia (Baker and Rubin, 1989; Shilo and Raz, 1991) . We therefore tested several GAL4 strains with eye or wing expression. Figure 2 ras function is required to suppress apoptosis in the midline glia. During embryonic stage 14, normal MG apoptosis is not complete. Profiles of apoptotic nuclei were seen in most embryos (arrow, a). Expression of neu NT in the midline increased MG number, and no apoptotic profiles were seen at stage 14 (b). All AA142-labelled nuclei were apoptotic when dominant-negative ras N17 was expressed in the midline (c). When both neu NT and ras N17 were expressed in midline cells, most AA142 profiles were apoptotic (d). Arrows identify individual apoptotic profiles Misexpression of neu with many GAL4 drivers proved to be lethal before or during pupation, presumably a reflection of low levels of expression in other tissues. These effects were not seen in GAL4 drivers whose expression was restricted to postmitotic cells, or cells not required for viability. This is the case with P[GAL4]C96, expressed in the wing disc dorsal-ventral boundary and in Rhodopsin1-GAL4, expressed in differentiated photoreceptors. In contrast to the MG assay, phenotypes generated in the eye by the glass multimer reporter (GMR)-directed expression reveal a sensitivity to much lower levels of Neu signalling. neu NYPD expression in the eye results in a rough eye characterized by fewer, more irregular ommatidia than in wild type (Figure 3a) and randomly placed bristles (Figure 3b ). This was not unexpected, as Neu NYPD also retains weak transforming potential in mouse mammary tissue (Dankort et al., 2001) . The placement of ommatidia and bristles was slightly more regular in p[GMR]; p[UAS-neuYA] flies (Figure 3c ), although significantly modified from wild type. GMRdirected expression of the other neu alleles was pupal lethal. The 1.3% of p[GMR]; p[UAS neuYC] that survive to eclosion had a severely reduced eye with no ommatidial structure (Figure 3d ).
Identification of adaptors required for Neu signalling in Drosophila
For our genetic screen for modifiers of neu signalling, we selected the C96 GAL4 enhancer trap, in which Figure 4 Signalling by Neu at the wing margin. Expression of activated Drosophila EGF receptor at the wing margin with C96 GAL4 resulted in notch formation on the posterior margin (b). Similar expression of neu NT resulted in the widening of wing veins near the wing margin, and also notch formation (c). Although expression of neu YA (e) did not alter morphology relative to a control C96 wing (a), the other neu add-back alleles resulted in differing severity of notch and margin phenotypes. (f-i), neu transgene indicated at the upper right). Arrows indicate widened wing veins and arrowheads mark wing margin notches in all panels, and also in an enlargement of a neu YB wing (j, left) and a neu YE wing (j, right)
Neu activates Drosophila effector pathways M Settle et al expression is restricted to cells at the dorsal to ventral boundary of the wing (Gustafson and Boulianne, 1996; Stewart et al., 2001) . Expression of activated DEgfr in the wing margin generated notches on the posterior half of the margin, possibly resulting from cell death during growth of the wing disc (Figure 4b ). With one exception (see below), expression of Neu transgenes generated similar notches, as well as expanded wing vein tissue near the wing margin (Figure 4c-i) . This is likely a functional outcome of Neu signalling, because wing veins are specified by DEgfr signals (Sturtevant et al., 1993; Sturtevant and Bier, 1995) . The severity of the wing phenotypes ranks similarly to the degree of suppression of apoptosis in the MG. neu NT and neu
YD
show the strongest phenotypes, and neu YA had no phenotype. However, neu NYPD generated a relatively more severe phenotype and neu YB a less severe phenotype than might be predicted by the MG assay.
We have examined wings from C96; UAS-neu flies, also heterozygous, for amorphic alleles of genes for second messengers (raf, ras, dab, sos, and PLCg) and for adaptors (shc, Grb-2, Nck, and shp-2) thought to participate in signalling from Neu. The results are summarized in Table 2 , wherein no modification of phenotype was scored as 1 and complete suppression was given a score of 5. Suppression could not be scored from the wild-type morphology after neu YA expression (Figure 4e ). All neu-induced wing phenotypes were suppressed by a reduction in ras function except for neu YE (Table 2 ; Figure 5a , b). Phenotypes from Stronger suppression is scored by a higher number, to a maximum of 5 Figure 5 Genetic suppression of neu phenotypes in the wing. The wing phenotype resulting from neuYC expression in the wing margin was suppressed if the wing was also heterozygous for ras 5703 (a). However, the neu YE phenotype was unaffected by dosage of ras. Wings from flies heterozygous for DShc, which encodes an SH2-binding adaptor protein, reveal complete suppression of signalling from Neu YD (Figure 5e , f). A reduction in Grb-2 (drk), Gab-1 (dos), Dab (dab), or Shp-2 (csw) adaptor function attenuated signalling most potently from Neu YB . Nevertheless, these mutations weakly suppress phenotypes from other pTyr (Table 2; Figure 5g , h).
Discussion
In this report, we illustrate that expression of an activated mammalian EGFR family member in transgenic Drosophila generates phenotypes comparable to overactivation of the endogenous DEgfr pathway. The rat neu oncogene can suppress apoptosis in the MG lineage, generate a rough eye phenotype and expand the domains of wing veins, all characterized, dosagesensitive DEgfr hypermorphic phenotypes (Baker and Rubin, 1989; Sturtevant and Bier, 1995; Lanoue and Jacobs, 1999) . Furthermore, we have demonstrated that each of the five identified pTyrs of Neu are surrogate activators of evolutionarily conserved SH2/PTB signalling proteins and contribute to signalling in Drosophila tissues.
Gene function in Drosophila can be complemented in vivo by a number of mammalian transgenes, mostly transcription factors, such as Cut/CDP (Ludlow et al., 1996) . Among adaptor proteins, both human GRB2 and Drosophila Drk can compensate C. elegans SEM-5 (Stern et al., 1993) . In these examples, complementation was predicted from the similarity of the primary sequence, and the conservation of the molecular mechanism.
Although RTK signalling appears to be conserved, some second messengers identified in mammals have no apparent ortholog in Drosophila, such as the p62 DOK family (Lock et al., 1999) . Furthermore, limited sequence similarities identified in the adaptor domain (Table 1) are not compelling evidence for conserved function. Therefore, it is striking that all pTyrs of Neu can signal in Drosophila. These suggest that the mechanism of RTK signalling is conserved and that orthologs can be functionally determined in Drosophila.
Neu suppresses apoptosis in the MG
Most pTyr residues identified with transforming signals in Neu also suppress apoptosis in the MG. Neu YD generated the most potent suppression of apoptosis.
Mammalian Shc associates with Neu YD , and further recruits Grb-2 through Y317 to signal to Ras (RozakisAdcock et al., 1993; Salcini et al., 1994; Lai et al., 1995) . Drosophila Shc lacks this pTyr, and likely signals through a Grb-2-independent pathway. Shc may also signal independently of GRB2 and Ras to the PI-3K/ Akt pathway, to provide an antiapoptotic signal (Gotoh et al., 1996; Gu et al., 2000) .
Neither Neu YA or Neu NYPD generates detectable antiapoptotic signals in the MG, although Neu NYPD signals affect eye and wing phenotype. The lack of an antiapoptotic effect from neu NYPD was unexpected, because the neu NYPD phenotype in the wing assay is slightly attenuated in a raf mutant background, and antiapoptotic signals in the MG act primarily through Raf (Kurada and White, 1998).
Neu signalling in imaginal tissues
Consistent with the apoptosis assay, all activating pTyr generated phenotypes when expressed in the developing eye or wing discs. Signalling through pTyr that was potent in the MG assay was lethal at the pupal stage when expressed in the eye. In contrast, expression in the margin of the wing generated a range of phenotypes with all pTyr, and again proved most sensitive to signalling from Neu YD . The lethal outcome after expression of some neu alleles in developing tissue was not unexpected, as signalling by Neu cannot be naturally regulated. The level of expression of the heterologous RTK cannot be modulated by intracellular signals when regulated by GAL4 transactivation. Furthermore, intracellular targeting and receptor downregulation signals in Drosophila may not recognize Neu. For example, DEgfr has a carboxyl-terminal PDZ binding motif that is lacking in Neu, which may function in the subcellular localization of the receptor (Whitfield et al., 1999) .
In contrast to the apoptosis assay, imaginal expression of Neu NYPD generated a hypermorphic phenotype, although lacking a characterized transforming pTyr. Neu NYPD has transformation potential in mammals, but it is possible that Neu NYPD transactivates other ErbB receptors to signal (Dankort et al., 2001) . Our data suggest that transactivation of a Drosophila RTK by Neu is unlikely, lending support to the notion that Neu NYPD can activate other signals (Dankort et al., 2001) . The Drosophila eye provides a promising genetic assay to identify these messengers.
Neu YA provides inhibitory signals, and normally attenuates outputs from other pTyr (Dankort et al., 1997) . Neu YA generates no wing phenotype and a minor eye phenotype; both may reflect inhibitory feedback upon the NYPD signal. If so, identification of mutations that confer a phenotype to Neu YA may reveal genes required for repression of RTK signalling.
Dosage modifier genetics of Neu signalling
Novel components of a specific signal transduction pathway have been uncovered in screens for genetic Neu activates Drosophila effector pathways M Settle et al enhancers or suppressors of a phenotype of a dominant allele. Productive screens have employed eye or wing phenotypes, and provided the first identification of second messengers like ksr, sos and tws (Rogge et al., 1991; Simon et al., 1991; Sturtevant and Bier, 1995; Therrien et al., 1995; Maixner et al., 1998) . Moreover, such screens have provided a wealth of information to form heirarchies of gene function in signal transduction. Dominant phenotypes generated by a mammalian oncogene expressed in Drosophila can also be used in a modifier screen to reveal new genes involved in wellstudied signal transduction pathways, such as Wnt/wg signalling (Bhandari and Shashidhara, 2001 ). This report demonstrates that dosage modifier genetics in Drosophila can also be used to map out signal transduction pathways activated by an oncogenic RTK.
Phenotypes generated by neu in Drosophila tissue should be sensitive to the levels of adaptor second messenger protein available to propagate the signal. Protein levels may be reduced in Drosophila when they are heterozygous for the gene in question. Therefore, adaptor or second messenger function can be associated with output of a specific pTyr when a genetic interaction is detected between a mutation in the respective Drosophila gene and the mammalian transgene. Our modifier survey of several Drosophila signal transduction genes reveals interesting aspects of Neu signalling relevant to the understanding of function in oncogenesis. For instance, peptide binding studies predict that Shc should bind to, and signal from, pTyr YC and YE (van der Geer et al., 1996) but Shc will immunoprecipitate with NeuYD in a sequence-specific fashion (Dankort et al., 1997 (Dankort et al., , 2001 ). Our genetic data suggest that YD is the primary, and possibly sole, pTyr that interacts with DShc.
Binding of Grb-2 to YB is required for transformation of rat fibroblasts by Neu YB (Dankort et al., 1997) . Grb-2 inhibitory polypeptides were effective in suppressing signals from Neu YB (Dankort et al., 2001) . Our genetic data did not demonstrate that YB is the primary recruitment site for Drosophila Grb-2. Instead, we found that mutations in drk suppress signals from multiple pTyr, including YB. However, when we similarly tested genes whose function is required upstream or downstream of drk (in Drosophila orthologs of Sos, Gab-1, Dab, Shp-2, and Ras), we observed more specific suppression of neu YB wing phenotypes. Dab2 (dab) (Le and Simon, 1998; Xu et al., 1998) and Sos, itself an activator of Ras, function downstream of Grb-2 (Lowenstein et al., 1992; Buday and Downward, 1993) . In Drosophila, Drk may also be activated by Shp-2 (csw), which itself may be recruited by Gab-1 (dos), which associates with both the DEgfr and Sev RTKs (Cleghon et al., 1998; Herbst et al., 1999; Johnson Hamlet and Perkins, 2001) . We observed strong suppression of neu YB signals by mutations in csw and dos. These genetic data suggest that a subset of Grb-2 functions are specifically associated with YB activation, and these functions are genetically similar to association with Sev or DEgfr RTKs because of the involvement of csw, dos, drk, and sos.
The modifier survey also reveals that not all pTyrs are sensitive to ras function. Competitive inhibition of Ras with Rap1A peptide attenuated fibroblast transformation signals from all pTyr, with less effect only with NeuYC (Dankort et al., 1997) . In contrast, we find Neu YC to be sensitive to reduced ras function, and that YE is insensitive to ras. Nevertheless, YE is sensitive to raf, suggesting a Ras-independent route to Raf activation triggered by YE.
Adaptors Nck and PLCg interact directly with ErbB-2 and Neu (Peles et al., 1991; Dougall et al., 1996) . However, a genetic interaction was not noted with the Drosophila orthologs, dock and sl. Similarly, our dosage modifier screen of Neu signalling in Drosophila supported some, but not all signalling pathways suggested from in vitro cell transformation experiments. In some cases, this may be because the gene in question is not dosage sensitive. Further studies with antimorphic or dominant-negative alleles may resolve this. In addition, structural differences between Drosophila and mammalian adaptors may alter the affinity of Drosophila adaptors for specific pTyr relative to the mammalian orthologue.
We observed that there are tissue-specific differences in the response to signals from individual pTyr. Extension of screens for modifiers of pTyr signalling to multiple tissues may begin to reveal the contextspecific differences in signalling between different cell types. Expanded genetic modifier screens after insertional or chemical mutagenesis will further explore the Drosophila genome for genes required for transaction of specific pTyr outputs. The mammalian orthologues of these candidates can then be characterized to further map out the network of signalling pathways triggered in oncogenic RTKs, and identify their roles in human malignancies.
Materials and methods
Transgenes
The generations of activated rat erb-B-2 (neu NT ), neu NYPD (phosphorylation deficient or tyrosine to phenylalanine transition at 1028,1144,1201,1226,1227, and 1253) and add-back alleles, restoring tyrosine to YA(Y1028), YB(Y1144), YC(1201), YD(Y1226/7), and YE(Y1253), were reported earlier (Dankort et al., 1997) . We generated a kinase inactive form of YD by ligating a neu K757M 5 0 NcoI fragment with a neu YD 3 0 NcoI fragment. Transgenes were shuttled from pcDNA3 vector as a Not1 fragment into PUAST.
Drosophila strains
Transgenic Drosophila were generated and mapped by standard procedures (Phelps and Brand, 1998) . p[UAS-ras N17 ] was provided by D Montell (Lee et al., 1996) , and p[UASDEgfr A887T ] was a gift from N Baker (Lesokhin et al., 1999) . Expression of p[UAS-neu] was regulated by p[GAL4] strains, simGAL4 (Xiao et al., 1996) , GMRGAL4 (Hay et al., 1997) , and C96 (Gustafson and Boulianne, 1996; Stewart et al., 2001) . Crosses with GMR-GAL4 were conducted at 181C to suppress a weak ommatidial defect intrinsic to this stock. 
Histology
Embryo fixation and immunocytochemistry was performed as described (Patel, 1994) employing anti-b-galactosidase antibody (Cappel, Costa Mesa, CA, USA) and visualized with horseradish peroxidase (HRP)-conjugated secondary antibody. Neu protein was detected with anti-ErbB-2 antibody (Oncogene Science), and amplified by avidin-biotin labelling (Vector Labs, Burlingame, CA, USA) and nickel contrast enhancement (Lanoue et al., 2000) . Averaged MG cell counts are presented with s.d. and number of segments counted.
Scanning electron microscopy
Cold anesthetized flies were mounted with a charcoal and white glue mixture, and visualized at 3.0 Torr on an Electroscan 2020 Environmental Scanning Electron Microscope.
Wing mounts
Cold anesthetized flies were dehydrated in ethanol. Clipped wings were stored in methyl salicylate prior to mounting in DPX resin (Aldrich, Milwaukee, WI, USA).
